window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 3, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Crigler–Najjar syndrome

  • Biologics & Biosimilars,Clinical Development,Drug approval,FDA,Funding,Pharmaceuticals and therapeutics,Rare Diseases,Regulatory Affairs

    Hansa Biopharma reports 135% Q4 revenue growth and BLA submission for imlifidase

    Hansa Biopharma has reported a 135% increase in fourth-quarter revenue [...]

    February 13, 2026
  • Biomanufacturing,Cell & Gene Therapy,Clinical Development,Rare Diseases,Regulatory Affairs

    Imlifidase enables gene therapy for Crigler–Najjar patients with AAV immunity

    Genethon and Hansa Biopharma report GNT-018-IDES trial data showing imlifidase [...]

    October 12, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Strategies to extend ketamine antidepressant effects identified in new study
    Categories: Central Nervous System, Mental health, Neurosciences, Research & Development
  • Bullfrog AI signs commercial agreement with top 5 global pharma company to identify novel target in major depressive disorder
    Categories: Artificial Intelligence, Digital Health, Mental health, Neurosciences, Research & Development
  • Bio-Sourcing and Tiny Cargo partner to develop oral monoclonal antibodies using milk exosomes
    Categories: Biotech, Drug Delivery & Formulation, Drug Development, Partnerships & Funding, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top